Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

154.69 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jul 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 716
Open 154.69
Bid (Size) 154.60 (1)
Ask (Size) 155.00 (1)
Prev. Close 154.69
Today's Range 154.69 - 154.69
52wk Range 143.13 - 175.97
Shares Outstanding 2,628,679,824
Dividend Yield 3.08%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks See Mixed Reactions Amid Geopolitical Tensions And Earnings Surprises
Concerns were exacerbated by comments from former President Trump, raising fears of geopolitical tensions. 
Via Talk Markets
Topics Government
Exposures Political
Why the dividend investor may take a look at NYSE:JNJ.
Uncovering Dividend Opportunities with JOHNSON & JOHNSON (NYSE:JNJ). 
Via Chartmill

Performance

YTD
-3.30%
-3.30%
1 Month
+3.99%
+3.99%
3 Month
+3.74%
+3.74%
6 Month
-4.79%
-4.79%
1 Year
-9.58%
-9.58%

More News

Read More
This Hidden Gem Vanguard ETF Is Chock-Full of Magnificent Stocks. Here's Why It's a Buy Now.
Via The Motley Fool
Topics ETFs
MarketBeat Week in Review – 7/15 - 7/19
Via MarketBeat
Topics Economy
Exposures Interest Rates
Comparative Study: Johnson & Johnson And Industry Competitors In Pharmaceuticals Industry
Via Benzinga
7 Consumer Staples Stocks to Buy at a 52-Week Low in July
Via InvestorPlace
3 Blue-Chip Stocks to Buy for Christmas in July
Via InvestorPlace
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
Via Investor's Business Daily
Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst
Via Benzinga
3 Dividend Stocks That Demand Investor Attention
Via InvestorPlace
These Analysts Revise Their Forecasts On Johnson & Johnson After Q2 Results
Via Benzinga
3 Blue-Chip Stocks to Buy If the Dow Crashes
Via InvestorPlace
Topics Stocks
Exposures US Equities
Microsoft To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
A Top-Tier Dividend Stock Every Passive-Income Investor Should Consider
Via The Motley Fool
Wall Street Gearing Up For Tech-Led Rebound Ahead Of Netflix Earnings: Economist Expects Soft Landing But Says Brace For Bigger Fed Rate Cuts If This Happens
Via Benzinga
Topics Economy
Exposures Interest Rates
Is Johnson & Johnson a Buy Now?
Via The Motley Fool
2 Magnificent S&P 500 Dividend Stocks Down 19% and 41% to Buy and Hold Forever
Via The Motley Fool
Topics Stocks
Exposures US Equities
Why Johnson & Johnson Stock Was a Winner on Wednesday
Via The Motley Fool
Stock Of The Day: Johnson & Johnson Hits Crucial Roadblock — Can It Break Through?
Via Benzinga
Johnson & Johnson (JNJ) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Nasdaq 100 Suffers Worst Day In 11 Months As Chipmakers Tumble On China Curbs; Magnificent 7 Wipe Out $500B : What's Driving Markets Wednesday?
Via Benzinga
European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment
Via Benzinga
Exposures COVID-19
Johnson And Johnson Continues To Focus On Medical Innovation
Via Benzinga
This Medical Giant's Stock Rebounds: A 15% Upside Is the Minimum
Via MarketBeat
Exposures COVID-19
JNJ Q2 2024 Sales Surge To $22.4 Billion, Beating Expectations
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.